12-110281790-A-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong
The NM_170665.4(ATP2A2):āc.1A>Gā(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
ATP2A2
NM_170665.4 start_lost
NM_170665.4 start_lost
Scores
5
10
1
Clinical Significance
Conservation
PhyloP100: 5.59
Genes affected
ATP2A2 (HGNC:812): (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2) This gene encodes one of the SERCA Ca(2+)-ATPases, which are intracellular pumps located in the sarcoplasmic or endoplasmic reticula of the skeletal muscle. This enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol into the sarcoplasmic reticulum lumen, and is involved in regulation of the contraction/relaxation cycle. Mutations in this gene cause Darier-White disease, also known as keratosis follicularis, an autosomal dominant skin disorder characterized by loss of adhesion between epidermal cells and abnormal keratinization. Other types of mutations in this gene have been associated with various forms of muscular dystrophies. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2019]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 20 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PS1
Another start lost variant in NM_170665.4 (ATP2A2) was described as [Likely_pathogenic] in Lovd
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-110281790-A-G is Pathogenic according to our data. Variant chr12-110281790-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 1693414.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-110281790-A-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP2A2 | NM_170665.4 | c.1A>G | p.Met1? | start_lost | 1/20 | ENST00000539276.7 | NP_733765.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP2A2 | ENST00000539276.7 | c.1A>G | p.Met1? | start_lost | 1/20 | 1 | NM_170665.4 | ENSP00000440045 | P3 | |
ATP2A2 | ENST00000308664.10 | c.1A>G | p.Met1? | start_lost | 1/21 | 1 | ENSP00000311186 | A1 | ||
ATP2A2 | ENST00000552636.2 | c.-257-814A>G | intron_variant | 4 | ENSP00000447406 | |||||
ATP2A2 | ENST00000377685.9 | c.1A>G | p.Met1? | start_lost, NMD_transcript_variant | 1/20 | 5 | ENSP00000366913 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1361376Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 672090
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1361376
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
672090
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 20, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1693414). Disruption of the initiator codon has been observed in individual(s) with Darier disease (PMID: 10441324, 28035777). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the ATP2A2 mRNA. The next in-frame methionine is located at codon 126. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 27, 2021 | Initiation codon variant in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Identified in a family with Darier disease in published literature (Ruiz-Perez et al., 1999); This variant is associated with the following publications: (PMID: 28035777, 23356892, 10441324) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
D
MutationTaster
Benign
D;D;D;D
PROVEAN
Uncertain
D;D
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
P;P
Vest4
MutPred
Gain of catalytic residue at N3 (P = 0.1532);Gain of catalytic residue at N3 (P = 0.1532);
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.